| MHNW | MHO | MANW | MAO |
---|---|---|---|---|
Presence of plaque | ||||
 Crude | 1 | 0.80 (0.55–1.16) | 1.41 (0.84–2.35) | 1.43 (0.99–2.06) |
 Model 1 | 1 | 0.98 (0.65–1.46) | 0.96 (0.55–1.68) | 1.42 (1.01–2.00) |
 Model 2 | 1 | 0.98 (0.65–1.47) | 0.91 (0.51–1.61) | 1.49 (1.03–2.16) |
 Model 3 | 1 | 0.98 (0.64–1.48) | 0.95 (0.53–1.70) | 1.49 (1.02–2.16) |
Plaque, moderate risk | ||||
 Prevalence (%) | 10.8 | 12.0 | 15.0 | 15.4 |
 Crude | 1 | 1.05 (0.63–1.73) | 1.53 (0.76–3.09) | 1.58 (0.99–2.53) |
 Model 1 | 1 | 1.22 (0.72–2.04) | 1.12 (0.54–2.31) | 1.57 (0.97–2.54) |
 Model 2 | 1 | 1.16 (0.68–1.97) | 1.09 (0.51–2.33) | 1.65 (1.01–2.68) |
 Model 3 | 1 | 1.28 (0.74–2.20) | 1.11 (0.50–2.44) | 1.87 (1.11–3.14) |
Plaque, high risk | ||||
 Prevalence (%) | 15.8 | 10.4 | 18.8 | 18.6 |
 Crude | 1 | 0.62 (0.38–1.02) | 1.32 (0.69–2.49) | 1.31 (0.86–1.99) |
 Model 1 | 1 | 0.77 (0.45–1.30) | 0.84 (0.42–1.67) | 1.33 (0.84–2.09) |
 Model 2 | 1 | 0.78 (0.45–1.34) | 0.89 (0.44–1.80) | 1.39 (0.87–2.19) |
 Model 3 | 1 | 0.84 (0.48–1.45) | 0.71 (0.33–1.50) | 1.25 (0.76–2.07) |